Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

PARP inhibition is therapeutic in CNS inflammation through immunomodulation

D. Hooper, R. Kean, T. Mikheeva, J. Mabley, C. Szabo, G. Scott

Med Sci Monit 2003; 9(1): 28-0 :: ID: 15080

Abstract

We have used a novel phenathridinone PARP inhibitor, PJ-34, to probe the contribution of PARP to the pathogenesis of the multiple sclerosis model, experimental allergic encephalomyelitis (EAE). PJ-34 administration to mice immunized with myelin basic protein (MBP) significantly reduced the incidence of the disease as well as delayed the onset and reduced the severity of clinical signs of EAE in the treated mice that became sick. The loss of blood-brain barrier (BBB) integrity that facilitates immune/inflammatory cell invasion into central nervous system (CNS) tissues in EAE was inhibited by PJ-34, as was T cell infiltration into the CNS. On the other hand, the accumulation of activated monocytes in the CNS was only partly inhibited in PJ-34-treated mice that remained healthy and similar to that of diseased controls in mice where treatment was less effective. Similar patterns were seen for the expression of TNF-a, ICAM-1, IFN-g, and iNOS in CNS tissues in that PJ-34-treated mice with EAE resembled sick controls and treated mice that remained healthy were comparable to normal mice. While PJ-34 did not affect MBP-specific T cell proliferation in vitro, the proliferative response of T cells from PJ-34-treated mice immunized with MBP was reduced. The isotype profile of the antigen-specific antibodies elicited by MBP immunization was also altered, from predominantly IgG2a to IgG1 and IgG2b, by PJ-34 treatment. These results indicate that PARP inhibition is therapeutic in EAE by changing the bias of the response to MBP from pathogenic Th1-associated CNS inflammation to a Th-2 dependent humoral response.

Keywords: CNS, MS/EAE, T cells

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis Patients

Med Sci Monit In Press; DOI: 10.12659/MSM.947630  

Clinical Research  

Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in T...

Med Sci Monit In Press; DOI: 10.12659/MSM.947450  

0:00

Clinical Research  

Impact of Voltage Level on Hospitalization and Mortality in Electrical Injury Cases: A Retrospective Analys...

Med Sci Monit In Press; DOI: 10.12659/MSM.947675  

Clinical Research  

Comparative Study of Plantar Load and Foot Posture Characteristics in Male Elite Squash Players and Non-Ath...

Med Sci Monit In Press; DOI: 10.12659/MSM.947828  

Most Viewed Current Articles

17 Jan 2024 : Review article   8,044,083

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,972

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   30,118

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   24,024

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750